Phenylketonuria clinical trials at UCSD
1 in progress, 0 open to new patients
Phase 3 Study to Evaluate the Efficacy & Safety of Self-Administered Injections of BMN165 by Adults With PKU
Sorry, in progress, not accepting new patients
The BMN 165 clinical development program has been designed to demonstrate the safety and efficacy of BMN 165 in reducing blood Phe concentrations in adults with PKU.
La Jolla, California and other locations
Last updated: December 22, 2017